Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming

Technical Update - Maersk eyeing sub 10K levels. Novo higher but correction looming

Equities 3 minutes to read
Kim Cramer Larsson

Technical Analyst, Saxo Bank

Summary:  Maersk is being hit hard after earnings disappointment and can very well re-visit sub 10K levels
Novo moving higher but uptrend stretched and indicators are warning about a short-term correction. Longer-term there could be further upside

A.P. Moller Maersk (B) is down approx. 14% after disappointing earnings announcement trading well below support at around 11,360.
Daily RSI is currently below 40 threshold and if closing below there is further downside potential for the beaten down share. No strong support until around 10,320-9,820.

The rising traded volume is further confirming the downtrend

For Maersk to demolish and reverse this bearish outlook a close of the gap created today i.e., a close above 12,185 is needed.
That scenario is quite unlikely to play out

Source all charts and data: Saxo Group

Novo Nordisk seems unstoppable. However, uptrend is short-term a bit stretched with daily RSI above 80. But there is no divergence indicating Novo could move higher before a correction is hitting.
A move to 839 which is 200% of the latest correction that took place in Q4 2023 – see weekly chart – is likely.

If Novo is closing around current trading levels – or higher – the RSI on the weekly chart has broken its falling trend. There will still be divergence however, but closing above its falling trendline is indicating the divergence could be cancelled. It will require an RSI close above the horizontal dashed line.

Long-term monthly chart Novo has cancelled its RSI divergence by closing January above the dashed line. Currently above 90 RSI is at an extreme (RSI values ranges from 0 to 100) i.e., massively overbought BUT there is no divergence suggesting Novo could continue higher. However, it is ripe for a correction.

There is a warning sign in the form of declining volume. Basically, less and less buyers are pushing the stock higher, that is not sustainable

Support area around 795.70-774.30. A close below could ignite a larger correction down to around 725-700  

We’ll keep an eye out for a top and reversal pattern to emerge
Author is holding a position in Novo

Saxo Capital Markets (Australia) Limited prepares and distributes information/research produced within the Saxo Bank Group for informational purposes only. In addition to the disclaimer below, if any general advice is provided, such advice does not take into account your individual objectives, financial situation or needs. You should consider the appropriateness of trading any financial instrument as trading can result in losses that exceed your initial investment. Please refer to our Analysis Disclaimer, and our Financial Services Guide and Product Disclosure Statement. All legal documentation and disclaimers can be found at

The Saxo Bank Group entities each provide execution-only service. Access and use of Saxo News & Research and any Saxo Bank Group website are subject to (i) the Terms of Use; (ii) the full Disclaimer; and (iii) the Risk Warning in addition (where relevant) to the terms governing the use of the website of a member of the Saxo Bank Group.

Saxo News & Research is provided for informational purposes, does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. No Saxo Bank Group entity shall be liable for any losses that you may sustain as a result of any investment decision made in reliance on information on Saxo News & Research.

To the extent that any content is construed as investment research, such content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication.

None of the information contained here constitutes an offer to purchase or sell a financial instrument, or to make any investments.Saxo Capital Markets does not take into account your personal investment objectives or financial situation and makes no representation and assumes no liability as to the accuracy or completeness of the information nor for any loss arising from any investment made in reliance of this presentation. Any opinions made are subject to change and may be personal to the author. These may not necessarily reflect the opinion of Saxo Capital Markets or its affiliates.

Please read our disclaimers:
- Full Disclaimer (
- Analysis Disclaimer (
- Notification on Non-Independent Investment Research (

Saxo Capital Markets (Australia) Limited
Suite 1, Level 14, 9 Castlereagh St
Sydney NSW 2000

Contact Saxo

Select region


The Saxo trading platform has received numerous awards and recognition. For details of these awards and information on awards visit

Saxo Capital Markets (Australia) Limited ABN 32 110 128 286 AFSL 280372 (‘Saxo’ or ‘Saxo Capital Markets’) is a wholly owned subsidiary of Saxo Bank A/S, headquartered in Denmark. Please refer to our General Business Terms, Financial Services Guide, Product Disclosure Statement and Target Market Determination to consider whether acquiring or continuing to hold financial products is suitable for you, prior to opening an account and investing in a financial product.

Trading in financial instruments carries various risks, and is not suitable for all investors. Please seek expert advice, and always ensure that you fully understand these risks before trading. Saxo Capital Markets does not provide ‘personal’ financial product advice, any information available on this website is ‘general’ in nature and for informational purposes only. Saxo Capital Markets does not take into account an individual’s needs, objectives or financial situation. The Target Market Determination should assist you in determining whether any of the products or services we offer are likely to be consistent with your objectives, financial situation and needs.

Apple, iPad and iPhone are trademarks of Apple Inc., registered in the US and other countries. AppStore is a service mark of Apple Inc.

The information or the products and services referred to on this website may be accessed worldwide, however is only intended for distribution to and use by recipients located in countries where such use does not constitute a violation of applicable legislation or regulations. Products and Services offered on this website is not intended for residents of the United States and Japan.

Please click here to view our full disclaimer.